RS50475B - Derivati arilpiperazina kao selektivni ligandi dopaminskog receptora d3 - Google Patents
Derivati arilpiperazina kao selektivni ligandi dopaminskog receptora d3Info
- Publication number
- RS50475B RS50475B RSP-2007/0298A RSP20070298A RS50475B RS 50475 B RS50475 B RS 50475B RS P20070298 A RSP20070298 A RS P20070298A RS 50475 B RS50475 B RS 50475B
- Authority
- RS
- Serbia
- Prior art keywords
- group
- alkyl
- fused
- optionally
- optionally substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0411303A FR2877005A1 (fr) | 2004-10-22 | 2004-10-22 | Nouveaux derives d'arylpiperazine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS50475B true RS50475B (sr) | 2010-03-02 |
Family
ID=34951190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RSP-2007/0298A RS50475B (sr) | 2004-10-22 | 2005-10-18 | Derivati arilpiperazina kao selektivni ligandi dopaminskog receptora d3 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7432269B2 (sr) |
| EP (1) | EP1659112B1 (sr) |
| JP (1) | JP2006117677A (sr) |
| AT (1) | ATE365156T1 (sr) |
| CY (1) | CY1107482T1 (sr) |
| DE (1) | DE602005001434T2 (sr) |
| DK (1) | DK1659112T3 (sr) |
| ES (1) | ES2289671T3 (sr) |
| FR (1) | FR2877005A1 (sr) |
| HR (1) | HRP20070285T3 (sr) |
| PL (1) | PL1659112T3 (sr) |
| PT (1) | PT1659112E (sr) |
| RS (1) | RS50475B (sr) |
| SI (1) | SI1659112T1 (sr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE031039T2 (en) * | 2007-03-29 | 2017-06-28 | Joint-Stock Company Obninsk Chemical Pharmaceutical Company | An antihistamine and an anti-allergenic agent and a method for its preparation |
| WO2009095438A1 (en) * | 2008-02-01 | 2009-08-06 | Neurosearch A/S | Novel aryl piperazine derivatives useful as modulators of dopamine and serotonin receptors |
| HU1000676D0 (en) | 2010-12-17 | 2011-02-28 | Pharmahungary 2000 Kft | Inhibitors of matrix metalloproteinase, pharmaceutical compositions thereof and use of them for preventing and treating diseases where the activation of mmp is involved |
| CN112745261A (zh) * | 2020-02-27 | 2021-05-04 | 广东聚华印刷显示技术有限公司 | 电子传输材料及其制备方法、电子器件和显示装置 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1450443A (fr) | 1965-01-05 | 1966-06-24 | Inst Orch Khim An Ukr Ssr | 2-mercapto-5-aryloxazoles et leur procédé de préparation |
| DE2143730A1 (de) | 1971-09-01 | 1973-03-08 | Byk Gulden Lomberg Chem Fab | Substituierte pyridine, verfahren zu deren herstellung und sie enthaltende arzneimittel |
| BE792206A (sr) * | 1971-12-02 | 1973-06-01 | Byk Gulden Lomberg Chem Fab | |
| EP0036638A3 (en) | 1980-03-24 | 1982-10-20 | Diamond Shamrock Corporation | Herbicidal and plant growth regulant 2-sulfinyl and 2-sulfonyl pyridine n-oxides |
| ZA854887B (en) * | 1985-06-27 | 1986-02-26 | Beiersdorf Ag | Benzo(c)(1,8)naphthyridines processes for their preparation and their use,and formulations containing these compounds |
| US4843077A (en) * | 1987-06-09 | 1989-06-27 | Ortho Pharmaceutical Corporation | Isoquinoline derivatives having renal vasodilating properties and/or cardiotonic properties and/or phosphodiesterase inhibiting properties |
| FR2672052B1 (fr) * | 1991-01-28 | 1995-05-24 | Esteve Labor Dr | Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments. |
| DE19600934A1 (de) * | 1996-01-12 | 1997-07-17 | Basf Ag | Substituierte Aza- und Diazacycloheptan- und Cyclooctanverbindungen und deren Verwendung |
| TW593290B (en) * | 1996-05-10 | 2004-06-21 | Janssen Pharmaceutica Nv | Alkylaminobenzothiazole and -benzoxazole derivatives |
| US6313141B1 (en) * | 1997-06-13 | 2001-11-06 | Neurogen Corporation | 2-aminoalkylaminoquinolines as dopamine D4 ligands |
| WO1998056786A1 (en) * | 1997-06-13 | 1998-12-17 | Neurogen Corporation | 2-aminoalkylaminoquinolines as dopamine d4 ligands |
| US6031097A (en) * | 1997-10-27 | 2000-02-29 | Neurogen Corporation | 1-(N-(arylalkylaminoalkyl) aminoisoquinolines; a new class of dopamine receptor subtype specific ligands |
| WO1999021848A2 (en) * | 1997-10-27 | 1999-05-06 | Neurogen Corporation | Novel 1-(n'-(arylalkylaminoalkyl))aminoisoindoles; a new class of dopamine receptor subtype specific ligands |
| CN1325397A (zh) * | 1998-09-30 | 2001-12-05 | 纽罗根公司 | 2－哌嗪烷基氨基苯并吡咯衍生物∶多巴胺受体亚型特异配体 |
| EP1688412A3 (en) * | 2001-02-16 | 2006-08-16 | Aventis Pharmaceuticals, Inc. | Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| US7160888B2 (en) * | 2003-08-22 | 2007-01-09 | Warner Lambert Company Llc | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
-
2004
- 2004-10-22 FR FR0411303A patent/FR2877005A1/fr not_active Withdrawn
-
2005
- 2005-10-18 EP EP05292189A patent/EP1659112B1/fr active Active
- 2005-10-18 DK DK05292189T patent/DK1659112T3/da active
- 2005-10-18 DE DE602005001434T patent/DE602005001434T2/de active Active
- 2005-10-18 PL PL05292189T patent/PL1659112T3/pl unknown
- 2005-10-18 RS RSP-2007/0298A patent/RS50475B/sr unknown
- 2005-10-18 PT PT05292189T patent/PT1659112E/pt unknown
- 2005-10-18 SI SI200530040T patent/SI1659112T1/sl unknown
- 2005-10-18 AT AT05292189T patent/ATE365156T1/de active
- 2005-10-18 ES ES05292189T patent/ES2289671T3/es active Active
- 2005-10-19 US US11/252,870 patent/US7432269B2/en not_active Expired - Fee Related
- 2005-10-21 JP JP2005307524A patent/JP2006117677A/ja active Pending
-
2007
- 2007-06-29 HR HR20070285T patent/HRP20070285T3/xx unknown
- 2007-09-07 CY CY20071101161T patent/CY1107482T1/el unknown
-
2008
- 2008-03-07 US US12/044,243 patent/US20080167320A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1659112A1 (fr) | 2006-05-24 |
| HRP20070285T3 (en) | 2007-08-31 |
| US20060089364A1 (en) | 2006-04-27 |
| SI1659112T1 (sl) | 2007-12-31 |
| FR2877005A1 (fr) | 2006-04-28 |
| JP2006117677A (ja) | 2006-05-11 |
| CY1107482T1 (el) | 2013-03-13 |
| DE602005001434T2 (de) | 2008-02-07 |
| ATE365156T1 (de) | 2007-07-15 |
| DK1659112T3 (da) | 2007-10-15 |
| EP1659112B1 (fr) | 2007-06-20 |
| DE602005001434D1 (de) | 2007-08-02 |
| PT1659112E (pt) | 2007-09-27 |
| PL1659112T3 (pl) | 2007-11-30 |
| ES2289671T3 (es) | 2008-02-01 |
| US20080167320A1 (en) | 2008-07-10 |
| US7432269B2 (en) | 2008-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ601408A (en) | Novel 3-hydroxy-5-arylisothiazole derivative | |
| NZ594122A (en) | 2-Phenyl-N-(2-(6-(pyrrolidin-1-ylmethyl)thiazolo[5,4-b]pyridin-2-yl)phenyl)thiazole-4-carboxamide derivatives | |
| AR065337A1 (es) | Proceso para la sintesis de compuestos de 2- aminotiazol como inhibidores de quinasa, forma polimorfica | |
| NZ598582A (en) | Novel phenol derivative having uricsuric effect | |
| RU2009118602A (ru) | Производное индола | |
| RU2011146363A (ru) | Производные n-ацил-n-фенилпиперазина, используемые (кроме того) для профилактики или лечения диабета | |
| RS50475B (sr) | Derivati arilpiperazina kao selektivni ligandi dopaminskog receptora d3 | |
| JP2015531769A5 (sr) | ||
| WO2004080972A1 (en) | Pirazole modulators of atp-binding cassette transporters | |
| PE20081404A1 (es) | Derivados de sulfonil-fenil-2h-[1,2,4]oxadiazol-5-ona y procesos para su preparacion | |
| MX2010009959A (es) | Compuestos y metodo para reducir el acido urico. | |
| RS53180B (sr) | Novi inhibitori seh i njihova upotreba | |
| AR058698A1 (es) | Carbonatos de fenicol con accion antibiotica y composicion farmaceutica | |
| Miao et al. | Synthesis and potential antibacterial activity of new rhodanine-3-acetic acid derivatives | |
| ATE391711T1 (de) | Arylpiperazinderivate und deren verwendung als für den dopamin-d3-rezeptor selektive liganden | |
| Kai et al. | 2-Arylimino-5, 6-dihydro-4H-1, 3-thiazines as a new class of cannabinoid receptor agonists. Part 2: Orally bioavailable compounds | |
| WO2007099302A8 (en) | Methods of maintaining oral health in animals using morpholine derivatives | |
| ATE518538T1 (de) | Verwendung von substituierten piperazin- und morpholinderivaten | |
| NO20052475L (no) | Acylderivater av 5-(2-(4-(1,2 benzotiazol-3-yl)-1-piperazinyl)etyl)-6-klor-1,3-dihydro-2H-indol-2-on med neuroleptisk aktivitet. | |
| CA2422807A1 (en) | N-substituted benzothiophenesulfonamide derivatives | |
| Bongartz et al. | Synthesis and anti-angiogenic activity of 6-(1, 2, 4-thiadiazol-5-yl)-3-amino pyridazine derivatives | |
| MY144554A (en) | Pharmaceutical composition comprising 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole derivatives | |
| SI1674101T1 (sl) | Cinamatni derivati benzo(b)pirano(3,2-h)akridin-7-ona, postopek njihove priprave in farmacevtski sestavki, ki jih vsebujejo | |
| ATE479653T1 (de) | Carboxyalkoxy-substituierte acyl-carboxyphenyl- harnstoffderivate, verfahren zu ihre herstellung und ihre verwendung als arzneimittel | |
| Shi et al. | Design and synthesis of novel and potent amide linked PPARγ/δ dual agonists |